Haemonetics
HAE
$91.22
Share price
4.06%
Change (1 day)
9.72%
Change (1 year)
Categories
Number of shares outstanding for Haemonetics (HAE)
Number of shares outstanding as of April 2024 : 50,768,000
According to Haemonetics's latest financial reports and stock price the company's current number of shares outstanding is 50,768,000. At the end of 2023 the company had 50,768,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Haemonetics from 2012 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 50.76 M | 0.51% |
| 2022 | 50.5 M | -1.14% |
| 2021 | 51.09 M | 0.6% |
| 2020 | 50.78 M | 0.31% |
| 2019 | 50.63 M | -1.5% |
| 2018 | 51.4 M | -3.18% |
| 2017 | 53.09 M | 2.67% |
| 2016 | 51.7 M | 1.91% |
| 2015 | 50.74 M | -1.34% |
| 2014 | 51.43 M | -0.58% |
| 2013 | 51.73 M | 0.04% |
| 2012 | 51.7 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,407,200,000 | 4,641.57% | 🇺🇸 USA |
 Medtronic MDT | 1,329,700,000 | 2,519.17% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | 387,000,000 | 662.29% | 🇺🇸 USA |
 Baxter BAX | 507,000,000 | 898.66% | 🇺🇸 USA |
 Becton Dickinson BDX | 290,113,000 | 471.45% | 🇺🇸 USA |
 Stryker Corporation SYK | 380,000,000 | 648.50% | 🇺🇸 USA |
 PerkinElmer
PKI | 126,285,000 | 148.75% | 🇺🇸 USA |
 Cerus CERS | 180,938,000 | 256.40% | 🇺🇸 USA |